Anthony R. Flores, MD, MPH, PhD, FAAP, FPIDS
Anthony R. Flores, MD, MPH, PhD, FAAP, FPIDS
Specialty
Infectious Diseases, Pediatrics
M.S.
University of Rochester School of Medicine and Dentistry, Rochester, NY, 2002
Ph.D.
University of Rochester School of Medicine and Dentistry, Rochester, NY, 2004
M.P.H.
University of Rochester School of Medicine and Dentistry, Rochester, NY, 2006
M.D.
University of Rochester School of Medicine and Dentistry, Rochester, NY, 2006
Residency
Pediatrics, Accelerated Research Pathway - Baylor College of Medicine/Texas Children's Hospital, Houston, TX, 2008
Fellowship
Pediatric Infectious Diseases - Baylor College of Medicine/Texas Children's Hospital, Houston, TX, 2012
Clinical Interests
Bacterial Infections, Strep Throat, Pediatric Infectious Disease
Research Information
Dr. Flores is a physician-scientist with expertise in pediatric infectious diseases and Professor of Pediatrics at Vanderbilt University Medical Center. Dr. Flores’ research focuses on the bacterial genomic epidemiology and virulence mechanisms of pathogenic streptococci (group A and B streptococci) and is funded by grant awards from the NIH/NIAID. His research uses a combination of bacterial disease epidemiology, cutting-edge genomic technologies, and classical bacteriology techniques to understand epidemic clonal emergence and mechanisms of disease in streptococci. His work also includes examining the mechanisms of group A streptococcal carriage as a risk factor for disease in children.
In addition to pediatric infectious diseases consultations and research, Dr. Flores also has a strong interest in mentoring trainees and early career physician-scientists aimed at improving workforce diversity in pediatrics and research. In 2019, he spearheaded the formation and is the Chair of the Inclusion, Diversity, Access, & Equity (IDA&E) Committee of the Pediatric Infectious Diseases Society (PIDS). He has also led the collaboration between PIDS and the Academic Pediatric Association’s RAPID program to provide mentorship to early-stage investigators underrepresented in medicine and is part of the National Advisory Committee in the PIDS/APA RAPID Collaborative.